76 related articles for article (PubMed ID: 9850430)
1. Pharmacokinetics of a single dose of phenylpropanolamine following oral administration at two different times of the day.
Rao VV; Rambhau D; Rao BR; Srinivasu P
Arzneimittelforschung; 1998 Nov; 48(11):1087-90. PubMed ID: 9850430
[TBL] [Abstract][Full Text] [Related]
2. Time dependent pharmacokinetic interaction between phenylpropanolamine and chlorpheniramine maleate in human subjects.
Rao VV; Rambhau D; Rao BR; Srinivasu P
Drug Metabol Drug Interact; 1999; 15(4):259-68. PubMed ID: 10716040
[TBL] [Abstract][Full Text] [Related]
3. Relative bioavailability of carbinoxamine and phenylephrine from a retard capsule after single and repeated dose administration in healthy subjects.
Stockis A; Deroubaix X; Jeanbaptiste B; Lins R; Allemon AM; Laufen H
Arzneimittelforschung; 1995 Sep; 45(9):1009-12. PubMed ID: 7488301
[TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of carbinoxamine and phenylpropanolamine from a retard suspension after single dose administration in healthy subjects.
Stockis A; Lebacq E; Deroubaix X; Allemon AM; Laufen H
Arzneimittelforschung; 1992 Dec; 42(12):1478-81. PubMed ID: 1363194
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of pentoxifylline after oral administration of a sustained release tablet at two different times of the day.
Srinivasu P; Rambhau D; Rao BR; Rao YM
Arzneimittelforschung; 1999 Sep; 49(9):750-3. PubMed ID: 10514902
[TBL] [Abstract][Full Text] [Related]
6. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study.
Park JY; Kim KA; Park PW; Suh KH; Lee GS
Clin Ther; 2004 Dec; 26(12):2092-101. PubMed ID: 15823773
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
Cho HY; Moon JD; Lee YB
Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the orally administered decongestants pseudoephedrine and phenylpropanolamine in children.
Simons FE; Gu X; Watson WT; Simons KJ
J Pediatr; 1996 Nov; 129(5):729-34. PubMed ID: 8917241
[TBL] [Abstract][Full Text] [Related]
9. Combined pharmacokinetic and urodynamic study of the effects of oral administration of phenylpropanolamine in female Beagle dogs.
Noël S; Cambier C; Baert K; Gustin P; Denooz R; Massart L; Hamaide A
Vet J; 2010 May; 184(2):201-7. PubMed ID: 19282207
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral decongestants.
Kanfer I; Dowse R; Vuma V
Pharmacotherapy; 1993; 13(6 Pt 2):116S-128S; discussion 143S-146S. PubMed ID: 7507589
[TBL] [Abstract][Full Text] [Related]
11. Influence of morning or evening administration on absorption of theophylline.
Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
[TBL] [Abstract][Full Text] [Related]
12. Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administration.
Bethke TH; Merz M; Zech K; Seiberling M; Hauschke D; Heinze H; Wurst W
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):259-64. PubMed ID: 11430634
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability cf two amlodipine formulation in healthy volunteers.
Setiawati E; Sukmayadi ; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Deniati SH
Arzneimittelforschung; 2007; 57(7):467-71. PubMed ID: 17803060
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability of two cefadroxil products using serum and urine data in healthy human volunteers.
Otoom S; Hasan M; Najib N
Clin Exp Pharmacol Physiol; 2004 Jul; 31(7):433-7. PubMed ID: 15236630
[TBL] [Abstract][Full Text] [Related]
15. [Bioavailability of a controlled-release suspension of phenylpropanolamine in healthy volunteers].
Chen QC; Chen WL; Dai YQ; Ge GQ; Lin DC
Yao Xue Xue Bao; 1992; 27(4):299-302. PubMed ID: 1442046
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations.
Schran HF; Petryk L; Chang CT; O'Connor R; Gelbert MB
J Clin Pharmacol; 1996 Oct; 36(10):911-22. PubMed ID: 8930778
[TBL] [Abstract][Full Text] [Related]
17. Phenylpropanolamine and hemorrhagic stroke.
Wolowich WR; Casavant MJ; Ekins BR
N Engl J Med; 2001 Apr; 344(14):1094-5. PubMed ID: 11291666
[No Abstract] [Full Text] [Related]
18. [Pharmacokinetics of domestic actoprotector drug Metaprot in healthy volunteers].
Kibal'chich DA; Belolipetskaia VG; Blagodatskikh SV; Martsevich SIu; Rudenko LI; Iatsuk VR
Eksp Klin Farmakol; 2011; 74(6):30-2. PubMed ID: 21870773
[TBL] [Abstract][Full Text] [Related]
19. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.
Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ
Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233
[TBL] [Abstract][Full Text] [Related]
20. In-vivo pharmacokinetic characteristics of a transdermal phenylpropanolamine (PPA) preparation.
Devane J; Mulligan S; Foynes M; Martin M
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():297-9. PubMed ID: 1820895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
